• No results found

[PDF] Top 20 Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Has 10000 "Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation" found on our website. Below are the top 20 most common "Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation".

Allogeneic stem cell transplantation in patients with atypical
chronic myeloid leukaemia: a retrospective study from the
Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

... negative chronic myeloid leukaemia (CML), usually called atypical CML (aCML), rep- resents a very rare disease entity with aggressive clinical char- acteristics that usually confer a dismal ... See full document

7

Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

... previous retrospective study from Mohr et ...transplanted patients, which did not show any advantage compared to conventional therapy, with a 4-year probability of survival for the entire ... See full document

10

High dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

High dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

... 3 patients (2 patients with primary graft failure and one with secondary graft failure; one patient with missing ...29 patients (23%), manifested by a heterogeneous clinical presentation (Figure 1) ... See full document

8

High dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.

High dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.

... this study cohort, we used an objec- tive organ-specific symptom PRO to gain insight into the systemic response to ...of patients but with a general improvement in symptomatic scoring being reported in the ... See full document

9

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

... hematopoietic stem cell transplant is the only potentially curative option for patients with acute mye- loid leukemia (AML) in primary induction failure or re- fractory ...of patients ... See full document

10

Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood—a report from Eurocord, the Acute Le

Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood—a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation

... a retrospective study performed by the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT) group and by ... See full document

11

Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report

Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report

... bone marrow biopsy procured in April 2014 showed osteosclerosis and fibrosis grade 3, monolobu- lated bizarre megakaryocytes, increased erythropoiesis and myelopoiesis with reduced maturation, but no in- crease in ... See full document

6

Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation

Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation

... ectly from the EBMT registry supplemented by a standardised ques- tionnaire completed by the treating clinicians in each ...primary study endpoint was clinical disease response [deined below] assessed by ... See full document

8

Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review

Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review

... more patients) and twenty-two case reports (with one or two patients) were identified as relevant for the ...8 patients (n = 6), 15 studies were selected for further detailed ...one study that ... See full document

12

Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

... 65 patients with relapsed AML using augmented cytarabine based chemotherapy prior to ...these patients, and the median period between relapse and DLI was 19 ...of patients achieved a CR with DLI, yet ... See full document

25

Graßer, Christian
  

(2016):


	Allogene Stammzelltransplantation bei Patienten mit chronisch lymphatischer Leukämie (CLL) und verwandten Entitäten.


Dissertation, LMU München: Medizinische Fakultät

Graßer, Christian (2016): Allogene Stammzelltransplantation bei Patienten mit chronisch lymphatischer Leukämie (CLL) und verwandten Entitäten. Dissertation, LMU München: Medizinische Fakultät

... Mit einem Anteil von 88% war das periphere Blut des Spenders der Haupt- Entnahmeort der im Verlauf transplantierten Stammzellen. Es ergaben sich signi- fikant bessere Überlebenszeiten gegenüber der Verwendung von ... See full document

191

Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta analysis with trial sequential analysis

Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta analysis with trial sequential analysis

... our study merit ...of patients taking posaconazole for prophylaxis of IFI with and without TDM are limited, so we are not able to validate the practical benefit of posacona- zole TDM in clinical up to ... See full document

13

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

... Given the difficulty of diagnosing hypothyroidism in patients whose complaints (asthenia, cold intolerance, etc.) can easily be attributed to the causal disease or chemotherapy itself, it is important to regularly ... See full document

13

<p>Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Ho

<p>Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease</p>

... hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment for intermedi- ate/high-risk MDS and acute myeloid leukemia ...poietic stem cell ... See full document

9

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

... post-treatment cell counts and serum creatinine between two groups; these were analyzed using the paired ...in patients treated with Valganciclovir and Fos- carnet, compared with ... See full document

6

Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies.

Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies.

... Allo-HSCT is a very effective treatment option for patients with hematological malignancies who have HLA matched donors. The median time to engraftment was 19 days. The TRM was 19.5%, with infectious ... See full document

9

Regulatory γδ T cells induced by G CSF participate in acute graft versus host disease regulation in G CSF mobilized allogeneic peripheral blood stem cell transplantation

Regulatory γδ T cells induced by G CSF participate in acute graft versus host disease regulation in G CSF mobilized allogeneic peripheral blood stem cell transplantation

... Our study demonstrated that the proportion of γδTregs was signifi- cantly increased following G-CSF and/or TGF-β induc- ...lymphoma cell lines in the three induction and control groups did not significantly ... See full document

15

Case Report Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature

Case Report Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature

... EBV infection is considered to play a vital role in contributing to the development of DLBCL in AITL patients because of immunodeficiency [9]. However, EBER and serological evaluation of EBV DNA were both negative ... See full document

7

Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.

Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.

... resolution computed tomography patterns correlate with histolo- gical changes: including: (i) non-speci fi c interstitial pneumonia, which is the most commonly observed and characterized by a mixture of ground glass ... See full document

9

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature

... neutropenic patients or those with refractory invasive fungal disease, there was no further increase in exposure when the dose was increased from 400 mg to 600 mg twice daily ... See full document

6

Show all 10000 documents...